Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis

British Medical Journal

Volumn 320, Issue 7240, 2000, Pages 963-967

  Ashcroft, Darren M ^a   Li Wan Po, Alain ^a   Williams, Hywel C ^b   Griffiths, Christopher E M ^c  

^a ASTON UNIVERSITY   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CALCITRIOL; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; COAL TAR; CORTICOSTEROID; DESOXIMETASONE; DIFLORASONE DIACETATE; DITHRANOL; FLUOCINONIDE; HYDROCORTISONE; TACALCITOL; ULOBETASOL PROPIONATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; PSORIASIS; SKIN IRRITATION;

EID: 0034621026     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7240.963     Document Type: Article

References (34)

1. 1 Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976;30:107-14.
2. 2 Nevitt GJ, Hutchinson PE. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996;135:533-7.
3. 3 Gawkrodger DJ on behalf of the Therapy Guidelines and Audit Subcommittee of the British Association of Dermatologists. Current management of psoriasis. J Dermatol Treat 1997;8:27-55.
4. 4 Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
5. 5 Rothman KJ. Modern epidemiology. Boston: Little, Brown;1986:177-233.
6. 6 Li Wan Po A, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ 1997;315:1565-71.
7. 7 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
8. 8 Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomised clinical trials. Stat Med 1991;10:1665-77.
9. 3-analogue) as measured by blood, urine and bone density analysis in psoriatic patients [abstract]. Skin Pharmacol 1992;5:206-7.
10. 10 Griffiths WAD. Comparison of calcipotriol ointment and betamethasone ointment in the treatment of psoriasis vulgaris (parallel group). Presented at Daivonex, calcipotriol. A totally new treatment in psoriasis [abstract]. Athens, Greece, 1991.
11. 11 RT Plott. A double-blind study comparing the efficacy of diflorasone diacetate ointment 0.05% vs calcipotriene ointment 0.05% in the treatment of psoriasis [abstract]. Presented at the 54th annual meeting of the American Academy of Dermatology. Washington, DC;996:P-317.
12. 12 Bourke JF, Featherstone S, Iqbal SJ, Hutchinson PE. A double-blind comparison of topical calcitriol (3 μg/g) and calcipotriol (50 μg/g) in the treatment of chronic plaque psoriasis vulgaris [abstract]. Br J Dermatol 1995;133(suppl 45):17.
13. 13 Scarpa C. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid. Acta Derm Venereol (Stockh) 1994;186(suppl):47.
14. 14 Hutchinson PE, Berth-Jones J, Chalmers RJG, Chu AC, Griffiths WAD, Klaber MR. A comparison of calcipotriol ointment and short contact dithranol in the treatment of chronic plaque psoriasis [abstract]. Br J Dermatol 1992;127(suppl 40):17.
15. 15 Jurgensen HJ. A comparative study of Dovonex ointment and Dithrocream in treating psoriasis vulgaris [abstract]. Presented at the Dovonex Satellite symposium, 2nd Congress of the European Academy of Dermatology and Venereology. Athens, Greece 1991.
16. 16 Lehmann P, Kerscher M. Combination phototherapy of psoriasis with calcipotriene and narrow-band (311 nm) UVB [letter]. J Am Acad Dermatol 1997;36:501-2.
17. 17 Kerscher M, Volkenandt M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB [letter]. Lancet 1993;342:923.
18. 18 Kerscher M, Lehmann P, Plewig G. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB-light [abstract]. J Invest Dermatol 1996;1:107.
19. 19 Austad J. A comparative study of calcipotriol ointment in combination with UVB phototherapy and calcipotriol ointment alone in the treatment of psoriasis vulgaris [abstract]. Presented at the 27th Nordic Dermatology Congress. Finland, 1995.
20. 20 van de Kerkhof PCM. Calcipotriol cream and concurrent corticosteroids in psoriasis [abstract]. J Eur Acad Dermatol Venereol 1995;5(suppl 1):S184.
21. 21 Bourke JF, Berth-Jones J, Hutchinson PE. Occlusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris. Clin Exp Dermatol 1993:18:504-6.
22. 22 Berardesca E, Vignoli GP, Farinelli N, Vignini M, Distante F, Rabbiosi G. Non-invasive evaluation of topical colcipotriol versus dobetasol in the treatment of psoriasis. Acta Derm Venereol (Stockh) 1994;74:302-4.
23. 23 Baadsgaard O, Traulsen J, Roed-Petersen J, Jakobsen HB. Optimal concentration of tacalcitol in once-daily treatment of psoriasis. J Dermatol Treat 1995;6:145-50.
24. 24 Austad J. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis [abstract]. Aust J Dermatol 1997;38(suppl 2):45.
25. 3 analogue (MC903) in a double-blind study. Br J Dermatol 1988;119:223-30.
26. 20 Staberg B, Roed-Petersen J, Menné T. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. Acta Derm Venereol (Stockh) 1989;69:147-50.
27. 27 Schwartzel E, Blum R, Siskin S, Epinette W. A parallel group study evaluating the safety of 30 gram per day dosing of cacipotriene (BMS181161/MC903) ointment and its vehicle in patients with plaque psoriasis [abstract]. Presented at the 54th annual meeting of the American Academy of Dermatology. Washington, DC;1996:P-287.
28. 28 Köse O. Calcipotriol ointment vs clobetasol solution in scalp psoriasis [letter]. J Dermatol Treat 1997;8:287.
29. 29 Mallett RB, Coulson IH, Purkis PE, Leigh IM, Holden CA. An immunohistochemical analysis of the changes in the immune infiltrate and keratin expression in psoriasis treated with calcipotriol compared with betamethasone ointment. Br J Dermatol 1990;123:837.
30. 30 Arevalo A, Vega-Lopez F. Calcipotriol versus coal tar in Mexican patients with psoriasis [abstract]. J Eur Acad Dermatol Venereol 1995;5(suppl 1):S92.
31. 31 Katz HI, Lindholm JS, Wilde M, Siskin S, Wehr RW, Koeowald M, et al. A pilot, double-blind, bilateral, paired comparison of the efficacy, safety, and atrophogenic potential of calcipotriene ointment 0.005% versus its vehicle in the treatment of plaque psoriasis utilizing clinical evaluations and bioinstrumentation [abstract]. Presented at the 54th annual meeting of the American Academy of Dermatology. Washington, DC;1996:P-293.
32. 32 Munro CS and study group. Calcipotriol soft cream in treatment of body psoriasis [abstract]. J Invest Dermatol 1996;1:111.
33. 33 Van der Vleuten CJM, de Jong EMGJ, Rulo EHFC, Gerritsen MP, van de Kerkhof PCM. In-patient treatment with calcipotriol versus dithranol in refractory psoriasis. Eur J Dermatol 1995;5:676-9.
34. 34 Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CEM. Clinical measures of disease severity and outcome in psoriasis; a critical appraisal of their quality. Br J Dermatol 1999;141:185-91.